Jo Hilgers

3.0k total citations
76 papers, 2.3k citations indexed

About

Jo Hilgers is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Jo Hilgers has authored 76 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 32 papers in Radiology, Nuclear Medicine and Imaging and 25 papers in Immunology. Recurrent topics in Jo Hilgers's work include Monoclonal and Polyclonal Antibodies Research (31 papers), Glycosylation and Glycoproteins Research (25 papers) and Virus-based gene therapy research (13 papers). Jo Hilgers is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (31 papers), Glycosylation and Glycoproteins Research (25 papers) and Virus-based gene therapy research (13 papers). Jo Hilgers collaborates with scholars based in Netherlands, Japan and United States. Jo Hilgers's co-authors include Peter Kenemans, Gerard J. van Kamp, Silvia von Mensdorff‐Pouilly, Dick J. Schol, Rob A. Verstraeten, John Hilkens, A.A. Verstraeten, Sybren L. Meijer, Robert Leonard and Simon P. Langdon and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Jo Hilgers

76 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jo Hilgers Netherlands 30 1.1k 672 592 523 347 76 2.3k
L Hood United States 26 1.8k 1.6× 980 1.5× 501 0.8× 231 0.4× 446 1.3× 44 3.4k
Tapan K. Bera United States 34 1.5k 1.3× 1.0k 1.5× 356 0.6× 1.0k 1.9× 340 1.0× 87 3.6k
Lawrence D. Papsidero United States 23 842 0.7× 626 0.9× 471 0.8× 372 0.7× 140 0.4× 44 2.3k
Lucy F. Pemberton United States 27 3.2k 2.8× 813 1.2× 480 0.8× 340 0.7× 293 0.8× 39 3.9k
J. Hilgers Netherlands 28 1.0k 0.9× 651 1.0× 417 0.7× 545 1.0× 553 1.6× 91 2.3k
Mark S. Singer United States 22 1.7k 1.5× 1.6k 2.4× 469 0.8× 393 0.8× 137 0.4× 33 3.4k
J H Shaper United States 26 2.1k 1.8× 672 1.0× 229 0.4× 324 0.6× 705 2.0× 41 3.5k
S. O. Warnaar Netherlands 24 1.4k 1.3× 507 0.8× 629 1.1× 971 1.9× 438 1.3× 51 2.7k
Jerald J. Killion United States 25 1.5k 1.3× 450 0.7× 192 0.3× 1.2k 2.3× 217 0.6× 68 3.1k
Lambert G. Poels Netherlands 26 535 0.5× 453 0.7× 322 0.5× 213 0.4× 152 0.4× 64 1.7k

Countries citing papers authored by Jo Hilgers

Since Specialization
Citations

This map shows the geographic impact of Jo Hilgers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jo Hilgers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jo Hilgers more than expected).

Fields of papers citing papers by Jo Hilgers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jo Hilgers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jo Hilgers. The network helps show where Jo Hilgers may publish in the future.

Co-authorship network of co-authors of Jo Hilgers

This figure shows the co-authorship network connecting the top 25 collaborators of Jo Hilgers. A scholar is included among the top collaborators of Jo Hilgers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jo Hilgers. Jo Hilgers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berge, Rosita L. ten, Frank G.M. Snijdewint, Silvia von Mensdorff‐Pouilly, et al.. (2001). MUC1 (EMA) is preferentially expressed by ALK positive anaplastic large cell lymphoma, in the normally glycosylated or only partly hypoglycosylated form. Journal of Clinical Pathology. 54(12). 933–939. 33 indexed citations
2.
Nijman, Hans W., P J van Diest, Silvia von Mensdorff‐Pouilly, et al.. (2001). T cell infiltration and MHC I and II expression in the presence of tumor antigens: An immunohistochemical study in patients with serous epithelial ovarian cancer. European Journal of Obstetrics & Gynecology and Reproductive Biology. 94(1). 114–120. 21 indexed citations
3.
Nap, Marius, Laurent Bellanger, J. Brundell, et al.. (2001). Immunohistochemical Profiles of 30 Monoclonal Antibodies against Cytokeratins 8, 18 and 19. Tumor Biology. 22(1). 4–10. 10 indexed citations
4.
Urbani, Francesca, Roberto Lande, Arturo Sala, et al.. (2000). Functional topography of discrete domains of human CD38. Tissue Antigens. 56(6). 539–547. 23 indexed citations
5.
Kamp, Gerard J. van, et al.. (1999). Quantification of MUC1 in breast cancer patients. European Journal of Obstetrics & Gynecology and Reproductive Biology. 83(1). 67–75. 13 indexed citations
6.
Nijman, Hans W., Peter Kenemans, Rob A. Verstraeten, et al.. (1999). Influence of chemotherapy on the expression of p53, HER-2/neu and proliferation markers in ovarian cancer. European Journal of Obstetrics & Gynecology and Reproductive Biology. 83(2). 201–206. 17 indexed citations
7.
Cao, Yi, Uwe Karsten, & Jo Hilgers. (1998). Immunohistochemical Characterization of a Panel of 56 Antibodies with Normal Human Small Intestine, Colon, and Breast Tissues. Tumor Biology. 19(Suppl. 1). 88–99. 30 indexed citations
8.
Schol, Dick J., et al.. (1998). ‘Epitope Fingerprinting’ Using Overlapping 20-mer Peptides of the MUC1 Tandem Repeat Sequence. Tumor Biology. 19(Suppl. 1). 35–45. 30 indexed citations
9.
Kenemans, Peter, et al.. (1996). Serum tumor marker immunoassays in gynecologic oncology: Establishment of reference values. American Journal of Obstetrics and Gynecology. 174(1). 107–114. 73 indexed citations
10.
Hilgers, Jo, Silvia von Mensdorff‐Pouilly, A.A. Verstraeten, & Peter Kenemans. (1995). Quantitation of polymorphic epithelial mucin: a challenge for biochemists and immunologists. Scandinavian Journal of Clinical and Laboratory Investigation. 55(sup221). 81–86. 10 indexed citations
11.
Kenemans, Peter, Chris M.G. Thomas, L.F.A.G. Massuger, et al.. (1993). CA 125 serum levels in the early post-operative period do not reflect tumour reduction obtained by cytoreductive surgery. European Journal of Cancer. 29(7). 966–971. 29 indexed citations
12.
Kenemans, Peter, Th. Wobbes, C.M.G. Thomas, et al.. (1992). Use of Serum Tumor Markers in the Differential Diagnosis between Ovarian and Colorectal Adenocarcinomas. Tumor Biology. 13(1-2). 18–26. 51 indexed citations
13.
Schutter, Eltjo M.J., Jelle Visser, Gerard J. van Kamp, et al.. (1992). The Utility of Lipid-Associated Sialic Acid (LASA or LSA) as a Serum Marker for Malignancy. Tumor Biology. 13(3). 121–132. 51 indexed citations
14.
Lee, Sun Kyung, Chae Young Lim, Je G., et al.. (1991). Immunohistochemical distribution of MAM-3 and MAM-6 antigens in developing salivary glands of the human fetus. The Histochemical Journal. 23(8). 355–360. 4 indexed citations
15.
16.
Yamada, Kazuto, Takaaki Tanaka, Masahiko Mori, et al.. (1989). Immunohistochemical expression of MAM-3 and MAM-6 antigens in salivary gland tumours. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 415(6). 509–521. 11 indexed citations
17.
Massuger, Leon F.A.G., et al.. (1988). Pre-operative discrimination between benign and malignant ovarian tumors using a combination of CA125 and CA15.3 serum assays. International Journal of Cancer. 41(S3). 61–67. 35 indexed citations
18.
Tooze, J, Sharon A. Tooze, Hidde J. Haisma, & Jo Hilgers. (1985). AtT20 pituitary tumour cells contain mouse mammary tumour virus and intracisternal A-type particles in addition to murine leukemia virus.. PubMed. 39(1). 224–31. 8 indexed citations
19.
Hilgers, Jo & Mels Sluyser. (1981). Mammary tumors in the mouse.. Elsevier eBooks. 27 indexed citations
20.
Nowinski, Robert C., et al.. (1971). Characteristics of the structural components of the mouse mammary tumor virus. Virology. 46(1). 21–38. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L Hood Breakdown of academic impact, for papers by Tapan K. Bera Breakdown of academic impact, for papers by Lawrence D. Papsidero Breakdown of academic impact, for papers by Lucy F. Pemberton Breakdown of academic impact, for papers by J. Hilgers Breakdown of academic impact, for papers by Mark S. Singer Breakdown of academic impact, for papers by J H Shaper Breakdown of academic impact, for papers by S. O. Warnaar Breakdown of academic impact, for papers by Jerald J. Killion Breakdown of academic impact, for papers by Lambert G. Poels
Rankless by CCL
2026